The TIME-CHF (Trial of Intensified vs. Standard Medical Therapy in Elderly Patients With Congestive Heart Failure) trial reported high circulating levels of high-sensitivity C-reactive protein (hs-CRP) in patients with stable chronically reduced ejection fraction and preserved ejection fraction (EF) heart failure [4]. This evidence concerns the gene CRP and congestive heart failure.